Esketamine nasal spray
Indication
in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.
Grey
Brand:
Spravato
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommendation
LSCMMG Recommendation:
Grey
Reason for decision:
Prioritised for review
Supporting documents: